374 related articles for article (PubMed ID: 37142795)
1. The role of eIF4F-driven mRNA translation in regulating the tumour microenvironment.
Bartish M; Abraham MJ; Gonçalves C; Larsson O; Rolny C; Del Rincón SV
Nat Rev Cancer; 2023 Jun; 23(6):408-425. PubMed ID: 37142795
[TBL] [Abstract][Full Text] [Related]
2. A Cap for Every Occasion: Alternative eIF4F Complexes.
Ho JJD; Lee S
Trends Biochem Sci; 2016 Oct; 41(10):821-823. PubMed ID: 27283511
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus NS5A binds to the mRNA cap-binding eukaryotic translation initiation 4F (eIF4F) complex and up-regulates host translation initiation machinery through eIF4E-binding protein 1 inactivation.
George A; Panda S; Kudmulwar D; Chhatbar SP; Nayak SC; Krishnan HH
J Biol Chem; 2012 Feb; 287(7):5042-58. PubMed ID: 22184107
[TBL] [Abstract][Full Text] [Related]
4. mRNA- and factor-driven dynamic variability controls eIF4F-cap recognition for translation initiation.
Çetin B; O'Leary SE
Nucleic Acids Res; 2022 Aug; 50(14):8240-8261. PubMed ID: 35871304
[TBL] [Abstract][Full Text] [Related]
5. Targeting eukaryotic translation in mesothelioma cells with an eIF4E-specific antisense oligonucleotide.
Jacobson BA; Thumma SC; Jay-Dixon J; Patel MR; Dubear Kroening K; Kratzke MG; Etchison RG; Konicek BW; Graff JR; Kratzke RA
PLoS One; 2013; 8(11):e81669. PubMed ID: 24260583
[TBL] [Abstract][Full Text] [Related]
6. Manipulation of the host translation initiation complex eIF4F by DNA viruses.
Walsh D
Biochem Soc Trans; 2010 Dec; 38(6):1511-6. PubMed ID: 21118117
[TBL] [Abstract][Full Text] [Related]
7. Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells.
Frosi Y; Ramlan SR; Brown CJ
J Vis Exp; 2020 May; (159):. PubMed ID: 32421011
[TBL] [Abstract][Full Text] [Related]
8. Computational inference of eIF4F complex function and structure in human cancers.
Wu S; Wagner G
Proc Natl Acad Sci U S A; 2024 Jan; 121(5):e2313589121. PubMed ID: 38266053
[TBL] [Abstract][Full Text] [Related]
9. Vesicular stomatitis virus infection alters the eIF4F translation initiation complex and causes dephosphorylation of the eIF4E binding protein 4E-BP1.
Connor JH; Lyles DS
J Virol; 2002 Oct; 76(20):10177-87. PubMed ID: 12239292
[TBL] [Abstract][Full Text] [Related]
10. Deep computational analysis details dysregulation of eukaryotic translation initiation complex eIF4F in human cancers.
Wu S; Wagner G
Cell Syst; 2021 Sep; 12(9):907-923.e6. PubMed ID: 34358439
[TBL] [Abstract][Full Text] [Related]
11. Requirement of the eukaryotic translation initiation factor 4F complex in hepatitis E virus replication.
Zhou X; Xu L; Wang Y; Wang W; Sprengers D; Metselaar HJ; Peppelenbosch MP; Pan Q
Antiviral Res; 2015 Dec; 124():11-9. PubMed ID: 26526587
[TBL] [Abstract][Full Text] [Related]
12. Protein phosphatase 2A negatively regulates eukaryotic initiation factor 4E phosphorylation and eIF4F assembly through direct dephosphorylation of Mnk and eIF4E.
Li Y; Yue P; Deng X; Ueda T; Fukunaga R; Khuri FR; Sun SY
Neoplasia; 2010 Oct; 12(10):848-55. PubMed ID: 20927323
[TBL] [Abstract][Full Text] [Related]
13. Isolation and functional characterization of eIF4F components and poly(A)-binding protein from Plasmodium falciparum.
Tuteja R; Pradhan A
Parasitol Int; 2009 Dec; 58(4):481-5. PubMed ID: 19751846
[TBL] [Abstract][Full Text] [Related]
14. RNA-tethering assay and eIF4G:eIF4A obligate dimer design uncovers multiple eIF4F functional complexes.
Robert F; Cencic R; Cai R; Schmeing TM; Pelletier J
Nucleic Acids Res; 2020 Sep; 48(15):8562-8575. PubMed ID: 32749456
[TBL] [Abstract][Full Text] [Related]
15. Targeting the eIF4F translation initiation complex for cancer therapy.
Konicek BW; Dumstorf CA; Graff JR
Cell Cycle; 2008 Aug; 7(16):2466-71. PubMed ID: 18719377
[TBL] [Abstract][Full Text] [Related]
16. eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies.
Boussemart L; Malka-Mahieu H; Girault I; Allard D; Hemmingsson O; Tomasic G; Thomas M; Basmadjian C; Ribeiro N; Thuaud F; Mateus C; Routier E; Kamsu-Kom N; Agoussi S; Eggermont AM; Désaubry L; Robert C; Vagner S
Nature; 2014 Sep; 513(7516):105-9. PubMed ID: 25079330
[TBL] [Abstract][Full Text] [Related]
17. Translation initiation complex eIF4F is a therapeutic target for dual mTOR kinase inhibitors in non-Hodgkin lymphoma.
Demosthenous C; Han JJ; Stenson MJ; Maurer MJ; Wellik LE; Link B; Hege K; Dogan A; Sotomayor E; Witzig T; Gupta M
Oncotarget; 2015 Apr; 6(11):9488-501. PubMed ID: 25839159
[TBL] [Abstract][Full Text] [Related]
18. Cap-dependent mRNA translation and the ubiquitin-proteasome system cooperate to promote ERBB2-dependent esophageal cancer phenotype.
Issaenko OA; Bitterman PB; Polunovsky VA; Dahlberg PS
Cancer Gene Ther; 2012 Sep; 19(9):609-18. PubMed ID: 22767218
[TBL] [Abstract][Full Text] [Related]
19. Acquired Tamoxifen Resistance in MCF-7 Breast Cancer Cells Requires Hyperactivation of eIF4F-Mediated Translation.
Fagan DH; Fettig LM; Avdulov S; Beckwith H; Peterson MS; Ho YY; Wang F; Polunovsky VA; Yee D
Horm Cancer; 2017 Aug; 8(4):219-229. PubMed ID: 28577281
[TBL] [Abstract][Full Text] [Related]
20. Distinct interactions of eIF4A and eIF4E with RNA helicase Ded1 stimulate translation in vivo.
Gulay S; Gupta N; Lorsch JR; Hinnebusch AG
Elife; 2020 May; 9():. PubMed ID: 32469309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
